Fundz

Path Ai, Inc. reported raising $14.9 Million in an initial SEC Form D filing, from an offering of $15.4 Million

PRIVATENov 02, 2017$14.9M of $15.4M raised

Amount Raised

$14.9 Million

$14.9 Million sold, per SEC Form D (first sale Nov 2, 2017)

Round Type

Venture

BostonInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMachine LearningHealth Diagnostics

Who else raised in Health Diagnostics and Biotechnology around the same time

Companies in the same sectors as PathAI that raised within 45 days of this round, from Fundz verified event records.

  • Cleveland Diagnostics raised an undisclosed amount on December 13, 2017.
  • SRX Global Inc. raised $241K (Pre-Seed) on December 4, 2017.
  • Heartflow, Inc. raised $90M on December 4, 2017.
  • Check-Cap Ltd raised $2.1M (Seed) on November 22, 2017.
  • Progentec Diagnostics raised $1.3M (Seed) on November 21, 2017.
  • Rocket One raised $1M (Seed) on November 7, 2017.

Who to call at PathAI, and when

A new round usually means PathAI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PathAI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PathAI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PathAI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PathAI

Location

120 BROOKLINE AVE

Boston, Massachusetts, United States

About

PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of pathology interpretation, as well as to better gauge therapeutic efficacy and accelerate drug development for complex diseases. PathAI, which is headquartered in Boston, MA, and operates a CAP/CLIA-certified laboratory in Memphis, TN, is proud to have a team of 600+ innovative thinkers from around the globe. For more information, please visit www.pathai.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PathAI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAndy B., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for PathAI's next move

See what Strategic adds

PathAI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.